DE60220305D1 - Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten - Google Patents

Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten

Info

Publication number
DE60220305D1
DE60220305D1 DE60220305T DE60220305T DE60220305D1 DE 60220305 D1 DE60220305 D1 DE 60220305D1 DE 60220305 T DE60220305 T DE 60220305T DE 60220305 T DE60220305 T DE 60220305T DE 60220305 D1 DE60220305 D1 DE 60220305D1
Authority
DE
Germany
Prior art keywords
receptor antagonists
benzodiazepines
bicyclic
broken
vasopressin receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60220305T
Other languages
English (en)
Other versions
DE60220305T2 (de
Inventor
Alexey B Dyatkin
William J Hoekstra
Bruce E Maryanoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE60220305D1 publication Critical patent/DE60220305D1/de
Application granted granted Critical
Publication of DE60220305T2 publication Critical patent/DE60220305T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60220305T 2001-10-29 2002-10-11 Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten Expired - Fee Related DE60220305T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34104901P 2001-10-29 2001-10-29
US341049P 2001-10-29
PCT/US2002/032789 WO2003037901A1 (en) 2001-10-29 2002-10-11 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists

Publications (2)

Publication Number Publication Date
DE60220305D1 true DE60220305D1 (de) 2007-07-05
DE60220305T2 DE60220305T2 (de) 2008-01-17

Family

ID=23336043

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60220305T Expired - Fee Related DE60220305T2 (de) 2001-10-29 2002-10-11 Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten

Country Status (12)

Country Link
US (1) US6936604B2 (de)
EP (1) EP1442040B1 (de)
JP (1) JP2005507939A (de)
KR (1) KR20050035173A (de)
CN (1) CN1608068A (de)
AT (1) ATE362934T1 (de)
CA (1) CA2465497A1 (de)
DE (1) DE60220305T2 (de)
ES (1) ES2287326T3 (de)
HU (1) HUP0401722A3 (de)
PL (1) PL370114A1 (de)
WO (1) WO2003037901A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1809296A4 (de) * 2004-10-28 2009-03-11 Janssen Pharmaceutica Nv Neue [1,4]-benzodiazepine als vasopressin v2-rezeptorantagonisten

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860600A (en) * 1972-07-10 1975-01-14 Sterling Drug Inc Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5985869A (en) * 1989-10-20 1999-11-16 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US5521173A (en) * 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
US5700796A (en) * 1995-01-17 1997-12-23 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AU732214C (en) 1997-03-31 2001-10-25 Wakamoto Pharmaceutical Co., Ltd. Biphenyl derivatives and drug composition
TR200102069T2 (tr) 1999-01-19 2001-11-21 Ortho-Mcneil Pharmaceutical, Inc. Vasopresin reseptörü antagonistleri olarak trisiklik benzodiazepinler.

Also Published As

Publication number Publication date
KR20050035173A (ko) 2005-04-15
US6936604B2 (en) 2005-08-30
HUP0401722A3 (en) 2008-07-28
ES2287326T3 (es) 2007-12-16
CN1608068A (zh) 2005-04-20
PL370114A1 (en) 2005-05-16
US20030119822A1 (en) 2003-06-26
EP1442040B1 (de) 2007-05-23
CA2465497A1 (en) 2003-05-08
WO2003037901A1 (en) 2003-05-08
EP1442040A1 (de) 2004-08-04
ATE362934T1 (de) 2007-06-15
DE60220305T2 (de) 2008-01-17
HUP0401722A2 (hu) 2005-01-28
JP2005507939A (ja) 2005-03-24

Similar Documents

Publication Publication Date Title
WO2005013894A3 (en) Benzodiazepine cgrp receptor antagonists
IL140622A0 (en) Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
WO2004092166A3 (en) Cgrp receptor antagonists
WO2005000807A3 (en) Benzodiazepine cgrp receptor antagonists
ATE509019T1 (de) Benzodiazepinspirohydantoine als cgrp- rezeptorantagonisten
BRPI0418112A (pt) inibidores de p-38 quinase bicìclico heterocìclicos
WO2004091514A3 (en) Cgrp receptor antagonists
ATE423769T1 (de) Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
ATE209207T1 (de) Androgen rezeptor modulator verbindungen und verfahren
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
ATE280172T1 (de) Isomere kondensierte pyrrolocarbazole und isoindolone
BG103548A (en) Vitronectine receptor antagonists
ATE342253T1 (de) Azabicycloderivate als antagonisten des muscarinischen rezeptors
HK1091200A1 (en) Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
WO2002011732A8 (en) Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists
DE60201892D1 (en) Aminomethylpyrrolochinazoline als thrombinrezeptor-antagonist
IL145645A0 (en) N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
DE60220305D1 (de) Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee